Healthy Extracts(HYEX)
$1.350.00 (0.00%)
HYEX
Healthy Extracts financials statements
$1.35
At close:0.00 (0.00%)
Want to see HYEX full AI Analyst Report?
Healthy Extracts (HYEX) Ratios
8 Followers
Healthy Extracts Ratios
HYEX's free cash flow for Q3 2026 was $-56.58K. For the 2026 fiscal year, HYEX's free cash flow was increased by $0.00 and operating cash flow was $-56.58K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.79 | 0.95 | 1.13 | 2.20 | 4.14 |
| Quick Ratio | 0.29 | 0.17 | 0.16 | 0.19 | 0.64 |
| Cash Ratio | 0.09 | 0.06 | 0.01 | 0.07 | 0.40 |
| Solvency Ratio | -0.19 | -0.43 | -1.47 | -1.10 | -3.64 |
| Operating Cash Flow Ratio | 0.10 | 0.16 | -0.25 | -0.37 | -1.61 |
| Short-Term Operating Cash Flow Coverage | 0.23 | 0.30 | -0.39 | -0.56 | -2.63 |
| Net Current Asset Value | $ -2.47M | $ -308.21K | $ 219.25K | $ 1.09M | $ 1.75M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.09 | 0.40 | 0.43 | 0.21 | 0.11 |
| Debt-to-Equity Ratio | 0.11 | 2.30 | 1.18 | 0.32 | 0.14 |
| Debt-to-Capital Ratio | 0.10 | 0.70 | 0.54 | 0.24 | 0.12 |
| Long-Term Debt-to-Capital Ratio | 0.06 | 0.35 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.16 | 5.79 | 2.76 | 1.48 | 1.23 |
| Debt Service Coverage Ratio | -0.86 | -0.16 | -1.82 | -1.38 | -4.77 |
| Interest Coverage Ratio | -4.49 | -0.98 | -12.68 | -13.99 | -36.02 |
| Debt to Market Cap | 0.15 | 0.15 | 0.05 | 0.04 | 0.02 |
| Interest Debt Per Share | 0.31 | 0.38 | 0.45 | 0.23 | 0.15 |
| Net Debt to EBITDA | -3.15 | -4.53 | -0.49 | -0.58 | -0.06 |
| Profitability Margins | |||||
| Gross Profit Margin | 53.69% | 61.39% | 65.24% | 60.92% | 47.42% |
| EBIT Margin | -20.92% | -5.88% | -90.26% | -40.49% | -128.89% |
| EBITDA Margin | -17.55% | -5.88% | -90.18% | -40.45% | -128.54% |
| Operating Profit Margin | -20.92% | -5.88% | -90.26% | -40.18% | -128.89% |
| Pretax Profit Margin | -19.53% | -27.00% | -99.48% | -43.67% | -135.57% |
| Net Profit Margin | -19.53% | -27.00% | -99.48% | -43.97% | -139.15% |
| Continuous Operations Profit Margin | -19.53% | -27.00% | -99.48% | -43.67% | -135.57% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.70% | 102.64% |
| EBT Per EBIT | 93.35% | 459.01% | 110.21% | 108.66% | 105.18% |
| Return on Assets (ROA) | -3.17% | -35.35% | -93.85% | -35.60% | -67.32% |
| Return on Equity (ROE) | -3.67% | -204.85% | -259.06% | -52.70% | -82.55% |
| Return on Capital Employed (ROCE) | -3.61% | -28.86% | -235.06% | -48.17% | -76.46% |
| Return on Invested Capital (ROIC) | -3.49% | -11.62% | -108.25% | -36.60% | -67.15% |
| Return on Tangible Assets | -14.27% | -50.56% | -128.81% | -47.92% | -88.12% |
| Earnings Yield | -6.23% | -11.24% | -11.78% | -7.23% | -13.62% |
| Efficiency Ratios | |||||
| Receivables Turnover | 24.03 | 282.95 | 81.66 | 21.28 | 10.99 |
| Payables Turnover | 19.26 | 23.00 | 7.40 | 9.64 | 20.68 |
| Inventory Turnover | 2.48 | 0.88 | 0.53 | 0.48 | 0.39 |
| Fixed Asset Turnover | 0.95 | 903.71 | 751.93 | 409.28 | 1416.21 |
| Asset Turnover | 0.16 | 1.31 | 0.94 | 0.81 | 0.48 |
| Working Capital Turnover Ratio | -20.29 | 43.07 | 3.80 | 1.58 | 0.74 |
| Cash Conversion Cycle | 143.56 | 398.79 | 642.10 | 733.84 | 942.83 |
| Days of Sales Outstanding | 15.19 | 1.29 | 4.47 | 17.15 | 33.20 |
| Days of Inventory Outstanding | 147.32 | 413.36 | 686.99 | 754.57 | 927.28 |
| Days of Payables Outstanding | 18.95 | 15.87 | 49.36 | 37.88 | 17.65 |
| Operating Cycle | 162.51 | 414.65 | 691.46 | 771.72 | 960.48 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.02 | 0.09 | -0.14 | -0.12 | -0.34 |
| Free Cash Flow Per Share | 0.02 | 0.09 | -0.14 | -0.12 | -0.37 |
| Dividend Paid and CapEx Coverage Ratio | 8.58 | 0.00 | 0.00 | -41.94 | -9.39 |
| Capital Expenditure Coverage Ratio | 8.58 | 0.00 | 0.00 | -41.94 | -9.39 |
| Operating Cash Flow Coverage Ratio | 0.06 | 0.30 | -0.37 | -0.56 | -2.63 |
| Operating Cash Flow to Sales Ratio | 0.04 | 0.09 | -0.17 | -0.15 | -0.61 |
| Free Cash Flow Yield | 1.03% | 3.77% | -1.98% | -2.50% | -6.66% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -16.05 | -8.96 | -8.49 | -13.84 | -7.34 |
| Price-to-Sales (P/S) Ratio | 3.13 | 2.40 | 8.44 | 6.09 | 10.22 |
| Price-to-Book (P/B) Ratio | 0.59 | 18.22 | 21.99 | 7.29 | 6.06 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 96.73 | 26.51 | -50.49 | -39.95 | -15.02 |
| Price-to-Operating Cash Flow Ratio | 85.45 | 26.51 | -50.49 | -40.90 | -16.62 |
| Price-to-Earnings Growth (PEG) Ratio | 0.24 | 0.13 | -0.06 | 0.25 | 0.17 |
| Enterprise Value Multiple | -21.01 | -45.35 | -9.86 | -15.62 | -8.01 |
| Enterprise Value | 16.64M | 8.31M | 22.10M | 14.23M | 15.10M |
| EV to EBITDA | -21.01 | -45.35 | -9.86 | -15.62 | -8.01 |
| EV to Sales | 3.69 | 2.67 | 8.89 | 6.32 | 10.30 |
| EV to Free Cash Flow | 113.77 | 29.46 | -53.15 | -41.49 | -15.14 |
| EV to Operating Cash Flow | 100.51 | 29.46 | -53.15 | -42.48 | -16.75 |
| Tangible Book Value Per Share | 0.26 | -0.10 | 0.08 | 0.41 | 0.66 |
| Shareholders’ Equity Per Share | 2.58 | 0.14 | 0.33 | 0.66 | 0.93 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.48 | 1.05 | 0.85 | 0.79 | 0.55 |
| Net Income Per Share | -0.09 | -0.28 | -0.85 | -0.35 | -0.77 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.01 | 1.03 |
| Interest Burden | 0.93 | 4.59 | 1.10 | 1.08 | 1.05 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.75 | 0.67 | 1.56 | 1.01 | 1.76 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.18 | 0.42 |
| Income Quality | -0.19 | -0.34 | 0.17 | 0.34 | 0.45 |
Currency in USD

